{{Rsnum
|rsid=9389370
|Gene=PDE7B
|Chromosome=6
|position=136110127
|Orientation=plus
|GMAF=0.259
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=PDE7B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 45.1 | 39.8 | 15.0
| HCB | 41.6 | 48.2 | 10.2
| JPT | 45.1 | 51.3 | 3.5
| YRI | 100.0 | 0.0 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 41.6 | 48.2 | 10.2
| CHD | 42.2 | 45.9 | 11.9
| GIH | 31.7 | 45.5 | 22.8
| LWK | 95.5 | 3.6 | 0.9
| MEX | 50.0 | 41.4 | 8.6
| MKK | 94.2 | 5.8 | 0.0
| TSI | 42.2 | 47.1 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=19850283
|Title=Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}